Insulet (PODD) Tops Q4 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall St futures jump as Democrats sweep midterms
- CVS Health plans to split into two public companies by 2028
- UBS starts bullish coverage on Ferrari Group on luxury logistics growth
- Citi cuts Adobe rating on ’rising risk of a hard reset’
- Apple shares slip amid guidance for tightening margins, slowing services growth
Tweet
Share
E-mail
Get Alerts PODD Hot Sheet
Price: $154.86 --0%
Financial Fact:
Total operating expenses: 53.22M
Today's EPS Names:
ATS, SICP, FTCO, More
Financial Fact:
Total operating expenses: 53.22M
Today's EPS Names:
ATS, SICP, FTCO, More
Join SI Premium – FREE
Insulet (NASDAQ: PODD) reported Q4 EPS of $0.24, $0.03 better than the analyst estimate of $0.21. Revenue for the quarter came in at $369.7 million versus the consensus estimate of $332.18 million.
For earnings history and earnings-related data on Insulet (PODD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- McDonald’s posts better-than-expected third-quarter comparable sales
- Twin Disc (TWIN) Tops Q1 EPS by 13c
- Fidelity National Information Services, Inc. (FIS) Tops Q3 EPS by 1c ; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
